Business Context and Reporting Period
This Form 8-K Current Report was filed by IMMUNIC, INC. on April 22, 2026, with the earliest event reported on April 14, 2026. The filing details a material modification to the rights of security holders involving a reverse stock split approved by stockholders at a special meeting.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company implemented a 1-for-10 reverse stock split of its common stock.
- Share Count Reduction: The number of issued and outstanding shares was reduced from approximately 136 million to approximately 13.6 million.
- Trading Details: Post-split trading under the symbol "IMUX" on the Nasdaq Capital Market commenced on April 27, 2026, with a new CUSIP identifier of 4525EP200.
- Derivative Adjustments: Proportionate adjustments were made to the exercise prices and share counts for all outstanding stock options, restricted stock units, and warrants.
- Fractional Shares: No fractional shares were issued. Instead, fractional interests were aggregated into whole shares, sold on the open market, and the proceeds were distributed in cash to affected stockholders.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the mechanics of the stock split. The primary operational update is the effective date of the split and the commencement of post-split trading.
Investor Verification Checklist
- Verify the new CUSIP number (4525EP200) for the New Common Stock.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Check for cash payments received in lieu of fractional shares.
- Review the adjusted exercise prices and share quantities for any held stock options or warrants.
- Monitor trading activity on the Nasdaq Capital Market starting April 27, 2026.